Flexus Biosciences' Series A Round

Flexus Biosciences raised a round of funding on October 30, 2013. Investors include Kleiner Perkins Caufield & Byers.

Flexus is a biotechnology company focused on the discovery, development, and commercialization of small-molecule cancer immunotherapies targeting regulatory T cells. The company is leveraging unexploi…

Articles about Flexus Biosciences' Series A Round: